SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

Nautilus Biotechnology, Inc. backtest

10 trend-following strategies were compared on the full daily history of Nautilus Biotechnology, Inc.. 9 beat buy-and-hold CAGR; Supertrend ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is Supertrend (CAGR 28.1%, MDD -50.4%).

Data 2020-08-07 ~ 2026-08-31daily bars 1,523 (6.1 years)Costs 0.5%Venue XNASMonthly snapshot 2026-08-31

Results by strategy

9 of 10 beat buy and hold (CAGR -32.5%, drawdown -97.2%).

Sharpe leader (same as main): Supertrend — CAGR 28.1%, MDD -50.4%, Sharpe 0.65, 25% exposure.

Return/drawdown alternative: Supertrend — CAGR is 60.6%p higher than buy and hold, while drawdown improves by 46.7%p (CAGR 28.1%, MDD -50.4%, exposure 25%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
Supertrend
period=29, mult=4.8
28.1%-50.4%0.650.564.5x825%
SMA 크로스오버
fast=13, slow=110
19.3%-61.0%0.540.322.9x1432%
EMA 크로스오버
fast=28, slow=71
17.6%-57.0%0.520.312.7x1233%
Keltner 채널 돌파
emaPeriod=55, atrPeriod=15, mult=1.6
13.8%-68.8%0.460.202.2x2021%
ADX / DI 방향성
period=19, threshold=21
13.7%-69.4%0.460.202.2x2421%
볼린저 밴드 돌파
n=54, k=2.7
13.0%-51.3%0.440.252.1x1014%
Donchian 채널 돌파
entryN=75, exitN=33
11.8%-59.8%0.440.202.0x826%
ROC 모멘텀
n=97, threshold=-0.02
7.3%-69.6%0.390.101.5x4236%
MACD
fast=17, slow=37, signal=14
-24.4%-92.0%-0.18-0.270.2x7348%
Parabolic SAR
step=0.05, maxStep=0.26
-33.7%-96.7%-0.31-0.350.1x22140%
Buy and hold-32.5%-97.2%-0.06-0.330.1x1100%
0.1 1x 2021 2022 2023 2024 2025 2026 SupertrendBuy and hold
Supertrend: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -24% -49% -73% -97% 2021 2022 2023 2024 2025 2026 Buy and holdSupertrend
Supertrend maximum drawdown -50.4% (2023-06-20 → 2025-10-10), recovered after 867 days.

Rules of the top strategy

Trades the direction of a volatility-based trend line that trails below/above price.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next